GlassScriptPhysician profile
Agnes Errihani
NPI 1619574084
$8,387.65
in general payments reported to CMS, 2019-2025
37 companies · $748 in 2025
The $748 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $873 · 2022: $1,800 · 2023: $2,724 · 2024: $2,242 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,509 · Education: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,509.33 |
| Education | $205.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,090.75 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Jazz Pharmaceuticals INC. | $637.41 | 2021-2024 | |
| Glaxosmithkline, LLC. | $626.82 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $564.35 | 2021-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.25 | 2021-2024 | Ofev, Stiolto Respimat |
| Mylan Specialty L.P. | $452.61 | 2021-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $440.32 | 2022-2024 | Opsumit, Uptravi |
| Grifols USA, LLC | $399.42 | 2022-2025 | Xembify, Prolastin-C Liquid |
| Genzyme Corporation | $296.37 | 2021-2024 | |
| Inspire Medical Systems, INC. | $293.52 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $269.65 | 2023-2025 | Lumryz |
| Bayer Healthcare Pharmaceuticals INC. | $238.19 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $237.76 | 2021-2025 | Dupixent |
| Baxter Healthcare | $228.43 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $210.32 | 2022-2024 | Tezspire |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $190.18 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $189.32 | 2021-2024 | Glassia |
| Axsome Therapeutics, INC. | $178.99 | 2023-2025 | Sunosi |
| Philips North America LLC | $177.70 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Genentech USA, INC. | $156.42 | 2021-2025 | Xolair |
| Ethicon INC. | $137.79 | 2023 | Monarch Platform |
| Merck Sharp & Dohme LLC | $135.23 | 2021-2025 | Winrevair, Zerbaxa |
| Electromed, INC. | $101.69 | 2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $95.17 | 2024-2025 | Purified Cortrophin Gel |
| Insmed, INC. | $94.56 | 2021-2024 | Arikayce |
| Idorsia Pharmaceuticals US INC | $79.24 | 2022-2024 | Quviviq |
| Advanced Respiratory, INC | $77.51 | 2021 | |
| Viatris Specialty LLC | $55.96 | 2025 | Yupelri |
| United Therapeutics Corporation | $48.47 | 2024 | Tyvaso |
| Pfizer INC. | $43.08 | 2024 | |
| Resmed Corp | $35.29 | 2025 | |
| Hikma Pharmaceuticals USA | $32.40 | 2023-2024 | Ryaltris |
| Ambu INC. | $28.50 | 2022 | |
| Inogen, INC. | $28.20 | 2023 | Inogen One G3 Oxygen Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pharming Healthcare, INC. | $24.90 | 2023 | Ruconest |
| Pulmonx Corporation | $15.88 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agnes Errihani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.